Senti Biosciences, Inc. Quarterly Debt-to-equity in % from Q4 2021 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Senti Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q4 2021 to Q2 2025.
  • Senti Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 171 %, a 124% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 171 +94.5 +124% Jun 30, 2025
Q1 2025 143 +78.9 +124% Mar 31, 2025
Q4 2024 125 +70.5 +129% Dec 31, 2024
Q3 2024 100 +52.9 +112% Sep 30, 2024
Q2 2024 76.1 +34.6 +83.5% Jun 30, 2024
Q1 2024 63.9 +26.5 +70.7% Mar 31, 2024
Q4 2023 54.7 +0.77 +1.43% Dec 31, 2023
Q3 2023 47.1 -189 -80% Sep 30, 2023
Q2 2023 41.5 +99 Jun 30, 2023
Q1 2023 37.4 +52.4 Mar 31, 2023
Q4 2022 53.9 +67.8 Dec 31, 2022
Q3 2022 236 Sep 30, 2022
Q2 2022 -57.5 Jun 30, 2022
Q1 2022 -15 Mar 31, 2022
Q4 2021 -13.8 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.